China’s SinoPharmtech Pays a Visit to Eurasian Academy of Good Practices

The guests were most impressed by the Academy’s VR Pharma Factory for Universities. After the presentation of the simulation-based learning solution, everyone had their chance to immerse themselves in the VR environment, explore the many capabilities of the facility, and take on the role of pharma inspectors.  
After that, Prof. Irina Spichak, Doctor of Pharmaceutical Sciences and Executive Director of EAGP, spoke about the Academy’s other areas of business. SinoPharmtech delegates expressed particular interest in participating in GxP-Profi, the international professional excellence awards. They also wish to create a similar academy of good practices in China, and, in turn, would like to invite EAGP to the second China–Russia Biopharma Technology & Business Cooperation Forum that will be held on 21 September in Moscow. Sinopharmtech is one of its organizers.
Part of Shanghai EDA Medical & Pharmaceutical Technology Co., Sinopharmtech was established in 2011 by China’s largest manufacturers of pharmaceutical equipment. The enterprise supplies hi-tech Chinese equipment, consumables and quality substances. Its top-priority areas of business include biopharmaceutics, in particular technology transfer.